PIERONI, MARIA
 Distribuzione geografica
Continente #
NA - Nord America 3.416
EU - Europa 3.152
AS - Asia 1.342
SA - Sud America 194
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.165
Nazione #
US - Stati Uniti d'America 3.362
IT - Italia 919
RU - Federazione Russa 513
GB - Regno Unito 495
CN - Cina 473
SG - Singapore 385
IE - Irlanda 356
SE - Svezia 201
VN - Vietnam 169
DE - Germania 159
BR - Brasile 158
UA - Ucraina 157
FR - Francia 141
HK - Hong Kong 111
FI - Finlandia 82
KR - Corea 40
ES - Italia 39
IN - India 32
CA - Canada 31
TR - Turchia 27
ZA - Sudafrica 24
BD - Bangladesh 23
BE - Belgio 22
MX - Messico 16
PL - Polonia 16
JP - Giappone 15
IQ - Iraq 14
AR - Argentina 12
CZ - Repubblica Ceca 10
AT - Austria 7
LT - Lituania 7
MA - Marocco 7
PK - Pakistan 7
CL - Cile 6
EC - Ecuador 6
ID - Indonesia 6
IR - Iran 6
CI - Costa d'Avorio 5
LB - Libano 5
NG - Nigeria 5
PH - Filippine 4
RO - Romania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
NL - Olanda 3
PT - Portogallo 3
SN - Senegal 3
UY - Uruguay 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
AZ - Azerbaigian 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
MK - Macedonia 1
ML - Mali 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.165
Città #
Southend 433
Fairfield 373
Dublin 353
Dallas 347
Ashburn 240
Singapore 238
Chandler 198
Santa Clara 165
Woodbridge 160
Seattle 152
Moscow 149
Beijing 144
Wilmington 143
Houston 141
Jacksonville 130
Ann Arbor 125
Cambridge 110
Siena 106
Hong Kong 103
San Jose 93
Princeton 64
Helsinki 52
Hefei 50
Ho Chi Minh City 50
Florence 45
Dearborn 43
Los Angeles 42
New York 41
Lastra a Signa 40
Seoul 38
Nanjing 37
Hanoi 33
Lauterbourg 33
The Dalles 32
Council Bluffs 30
San Mateo 30
Catania 28
Munich 26
Málaga 24
Boardman 23
Johannesburg 23
Milan 23
Gavirate 22
San Diego 22
Shanghai 22
Rome 20
Izmir 19
Nanchang 18
Buffalo 15
Changsha 14
Tokyo 14
Chicago 13
Orem 13
Da Nang 12
Shenyang 12
São Paulo 12
Toronto 12
Warsaw 12
Dong Ket 11
Frankfurt am Main 11
Fremont 11
Brussels 10
Hebei 10
Montreal 10
Phoenix 10
San Francisco 10
Trieste 10
Baghdad 9
Chennai 9
Düsseldorf 9
Montecatini Terme 9
Prato 9
Redondo Beach 9
Venezia 9
Napoli 8
Boston 7
Haiphong 7
Jiaxing 7
Kunming 7
Norwalk 7
Poplar 7
Arezzo 6
Brno 6
Columbus 6
Figline Valdarno 6
Grosseto 6
Madrid 6
Manchester 6
Menlo Park 6
Mexico City 6
Ningbo 6
Rio de Janeiro 6
Stockholm 6
Tianjin 6
Abidjan 5
Abuja 5
Belo Horizonte 5
Bengaluru 5
Clifton 5
Denver 5
Totale 5.276
Nome #
La chitotriosidasi: un sensibile biomarker di sarcoidosi 1.038
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis 341
Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease 277
Exhaled nitric oxide in interstitial lung diseases 270
Different effects of inhaled aspirinlike drugs on allergen-induced early and late asthmatic responses 252
Adaptive immune system in pulmonary sarcoidosis - comparison of peripheral and alveolar biomarkers 249
Mortality on the Waiting List for Lung Transplantation in Patients with Idiopathic Pulmonary Fibrosis: A Single-Centre Experience 243
Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma 234
Alveolar nitric oxide is related to periostin levels in idiopathic pulmonary fibrosis 231
Could NSAIDs have a role as antiasthmatic agents? 229
Acute exacerbation of idiopathic pulmonary fibrosis after inhalation of a water repellent 223
Pirfenidone therapy for familial pulmonary fibrosis: a real-life study. 222
NK and NKT-like cells in granulomatous and fibrotic lung diseases 215
The analysis of tryptase in serum of sarcoidosis patients 210
Pirfenidone in idiopathic pulmonary fibrosis: real-life experience in the referral centre of Siena 210
Attenuation of aspirin-induced bronchoconstriction by sodium cromoglycate and nedocromil sodium 208
Coronavirus HKU 1 infection with bronchiolitis, pericardial effusion and acute respiratory failure in obese adult female 207
Efficacy and tolerability of nimesulide in asthmatic patients intolerant to aspirin 206
Regulatory T Cells in Severe Persistent Asthma in the Era of Monoclonal Antibodies Target Therapies 204
Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions 199
Chitotriosidase: a sensitive biomarker of sarcoidosis 198
Inhaled loop diuretics as potential new anti-asthmatic drugs 193
IPF mortality in waiting list for lung transplantation 188
The Role of Urinary Calcium and Chitotriosidase in a Cohort of Chronic Sarcoidosis Patients 187
Peripheral and alveolar biomarkers of fibrotic hypersensitivity pneumonitis 187
Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma 179
Helicobacter pylori antibody positivity in idiopathic pulmonary fibrosis 174
Mortalità in lista per trapianto di polmone in pazienti affetti da fibrosi polmonare idiopatica 173
Time-limited protective effect of inhaled frusemide against aspirin-induced bronchoconstriction in aspirin-sensitive asthmatics 166
Protective effect of inhaled lysine acetylsalicylate on allergen-induced early and late asthmatic reactions 152
Valutazione dell'ossido nitrico nell'esalato delle polmoniti interstiziali idiopatiche 137
Protective effect of inhaled piretanide on the bronchial obstructive response to ultrasonically nebulized H2O. A dose-response study 136
Pulse oximetry oxyhemoglobin saturation in patients with idiopathic pulmonary fibrosis 130
Potentiation of the antireactive, antiasthmatic effect of inhaled furosemide by inhaled lysine acetylsalicylate 129
null 121
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience 102
Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis Serum and BAL levels of KL6 in chronic hypersensitivity pneumonitis 92
Real-life comparison between pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis 72
The value of urinary calcium as biomarker in chronic sarcoidosis 34
Serum concentrations of KL-6 in patients with IPF and lung cancer and serial measurements of KL-6 in IPF patients treated with antifibrotic therapy 32
Totale 8.250
Categoria #
all - tutte 22.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021167 0 0 0 0 0 0 0 0 0 59 58 50
2021/2022524 29 69 41 58 18 11 32 21 12 51 67 115
2022/2023666 44 69 80 85 63 134 19 46 70 32 16 8
2023/2024561 15 14 46 23 22 141 199 19 4 18 6 54
2024/2025972 55 46 104 35 138 60 56 39 38 46 108 247
2025/20262.228 180 310 270 308 515 88 316 54 78 109 0 0
Totale 8.250